ZYMERON CORPORATION

DHA SBIR DIRECT PHASE II H2D-0243 RAPID SAMPLE PROCESSING DEVICE TO SUPPORT BATTLEFIELD WOUND INFECTION DIAGNOSTICS

BILATERAL AGREEMENT TO ACCELERATE THE COMPLETION DATE.

DHA STTR PHASE 1 MEDICAL RESEARCH AND DEVELOPMENT PURCHASE ORDER FOR "PROPOSAL H23C-002-0028 "DEVELOPMENT OF WOUNDSHIELD FOR PSEUDOMONAS AERUGINOSA-CAUSED WOUNDS INFECTIONS"

RESEARCH AND DEVELOPMENT

DHA STTR PH I PROPOSAL H23B-001-0020 ,TOPIC DHA23B-001-0020 TITLE AN AUTOMATED BLOOD-IN, MIRNAS-OUT ASSAY TO DETECT CIRCULATING AND EXOSOME MIRNAS EGS 2300543 MEDICAL R AND D

DHA SBIR DIRECT TO PH II MEDICAL R&D CONTRACT AWARDED FROM PROPOSAL NO.-H2D-0119 FOR "DEVELOPMENT FOR SHOCKDEFENDER AGAINST HEMORRHAGIC SHOCK"

RAPID POINT OF CARE TEST TO SCREEN HUMAN PAPILLOMAVIRUS IN LOW-RESOURCE SETTINGS

RAPID POINT OF CARE TEST TO SCREEN HUMAN PAPILLOMAVIRUS IN LOW-RESOURCE SETTINGS

AUTOMATED PARTIAL OCCLUSION FOR TRUNCAL HEMORRHAGE CONTROL SBIR PHASE II AWARD

ZYMERON DHA SBIR PHASE I H231-004-0023 NOVEL AEROSOL THERAPY FOR IMMEDIATE AND SUSTAINED ARDS MANAGEMENT

SBIR TOPIC 441. ZYMERON WILL DEVELOP USER-FRIENDLY TECHNOLOGIES AND DEVICES TO CREATE AN AT-HOME HEPATITIS C VIRUS TEST.

AUTOMATED PARTIAL OCCLUSION FOR TRUNCAL HEMORRHAGE CONTROL SBIR PHASE II AWARD

MEDICAL RESEARCH AND DEVELOPMENT ARMY STTR PH II PROPOSAL NO. A2-8349 TITLED LONG LASTING DRUG IMPLANTS FOR MALARIA CHEMOPROPHYLAXIS. MODIFICATION P00001 - PROVIDE FUNDING FOR YEAR 2 TO FULLY-FUNDED CONTRACT.